Results 61 to 70 of about 7,887,672 (307)

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

Exploring Preferences for a Digital Single‐Session Intervention for Adolescent Siblings of Youth With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro   +10 more
wiley   +1 more source

Realization of the digital to analog converter for model of the voltage in network [PDF]

open access: yesНаучно-технический вестник Брянского государственного университета, 2016
The article discusses the disadvantages of digital measuring instruments. Formulated the task of modeling the measuring device for different waveforms and measurements with the use of microcomputers.
Goncharova O.A.
doaj   +1 more source

Signal multiplexer [PDF]

open access: yes, 1969
Impedance transformation device for signal ...
Kinsel, R. C.
core   +1 more source

A Signal for Technicolor?

open access: yes, 1992
We propose an interpretation for the ($l\bar l\gamma \gamma ,\ M_{\gamma \gamma }=60{\rm GeV}$) events, which have recently been reported by L3 group at LEP.
Bando, Masako, Maekawa, Nobuhiro
core   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Compact digital frequency counter with high resolution

open access: yesТехнологія та конструювання в електронній апаратурі, 2010
Principle of operation, brief technical and metrological characteristics of frequency counter UA Ч3-64/2 are observed. In addition to the frequency signal parameters, the frequency counter can also measure the time intervals with high resolution, and it ...
I. I. Krival   +3 more
doaj  

Millivolt signal limiter [PDF]

open access: yes, 1969
Low-voltage limiter circuit suppresses the output of platinum probes at temperatures beyond their operating range. The limiter circuit comprises an operational amplifier with a dual feedback loop.
Hansen, I. G., Peterson, V. S.
core   +1 more source

Optimal length and signal amplification in weakly activated signal transduction cascades

open access: yes, 2003
Weakly activated signaling cascades can be modeled as linear systems. The input-to-output transfer function and the internal gain of a linear system, provide natural measures for the propagation of the input signal down the cascade and for the ...
Chaves, Madalena   +2 more
core   +2 more sources

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy